Abdelmeguid AE, Topol EJ, Whitlow PL, et al. 1996. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation, 94:1528-36. [OpenAIRE]
Abdelmeguid AE, Topol EJ. 1996. The myth of the myocardial 'infarctlet' during percutaneous coronary revascularization procedures. Circulation, 94:3369-75. [OpenAIRE]
Akkerhuis KM, Alexander JH, Tardiff BE, et al. 2002. Minor myocardial damage and prognosis. Circulation, 105:554-6. [OpenAIRE]
Aronow HD, McRae T, Quinn MJ. 2002b. Patients on lipid-lowering therapy at the time of myocardial infarction have smaller infarcts: further evidence to suggest a salutary effect in acute coronary syndrome [abstract]. J Am Coll Cardiol, 39:318A. [OpenAIRE]
Aronow HD, Quinn MJ, Gurm HS. 2002a. Myocardial necrosis is halved in patients undergoing elective percutaneous coronary intervention who are pretreated with lipid-lowering therapy [abstract]. J Am Coll Cardiol, 39:32A. [OpenAIRE]
Bestehorn HP, Neumann FJ, Büttner HJ, et al. 2004. Evaluation of the oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention. The randomized, double-blind, placebo-controlled, multicenter verapamil slow-release for prevention of cardiovascular events after angioplasty (VESPA) trial. J Am Coll Cardiol, 43:2160-5. [OpenAIRE]
Califf RM, Abdelmeguid AE, Kuntz RE, et al. 1998. Myonecrosis after revascularization procedures. J Am Coll Cardiol, 31:241-51. [OpenAIRE]
Demir I, Yılmaz H, Ermi¸s C, et al. 2002. Treatment of no re-flow phenomenon with verapamil after primary stent deployment during myocardial infarction. Jpn Heart J, 43:573-80.
Dens J, Desmet W, Piessens J. 2003. An updated meta-analysis of calcium-channel blockers in the prevention of restenosis after coronary angioplasty. Am Heart J, 145:404-8.
Desmet WJ, Dens J, Coussement P, et al. 2002. Does adenosine prevent myocardial micronecrosis following percutaneous coronary intervention? The ADELINE pilot trial. ADEnosine Limit myocardial Necrosis. Heart, 88:293-5. [OpenAIRE]
Ellis S, Sorin JB, Lincoff AM, et al. 2001. Beta-blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise. Circulation, 104:2685-8. [OpenAIRE]
[ENCORE] The ENCORE Investigators. 2003. Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I Study (Evaluation of Nifedipine and Cerivastatin in Recovery of coronary Endothelial function). Circulation, 107:422-8.
[EPISTENT] The EPISTENT Investigators. 1998. Randomized placebocontrolled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet, 352:87-92.
Folts JD. 1997. Inhibition of platelet activity in vivo by amlodipine alone and combined with aspirin. Int J Cardiol, 62: S111-7.
Herrmann J, Lerman A, Baumgart D, et al. 2002. Preprocedural statin medication reduces the extent of per procedural non-Q-wave myocardial infarction. Circulation, 106:2180-3.